Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.
Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Nohara R, et al. Circ J. 2012;76(1):221-9. doi: 10.1253/circj.cj-11-0887. Epub 2011 Nov 16. Circ J. 2012. PMID: 22094911 Free article. Clinical Trial.
Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART study.
Yamazaki T, Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Yamazaki T, et al. Int Heart J. 2013;54(1):33-9. doi: 10.1536/ihj.54.33. Int Heart J. 2013. PMID: 23428922 Free article. Clinical Trial.
Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension study.
Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification For Atherosclerosis Regression Treatment (JART) Investigators. Nohara R, et al. Circ J. 2013;77(6):1526-33. doi: 10.1253/circj.cj-12-1149. Epub 2013 Mar 14. Circ J. 2013. PMID: 23486191 Free article. Clinical Trial.
Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study.
Kimura T, Kubo M, Takahashi K, Wamata R, Iwamoto Y, Iwamoto H, Katakura Y, Sanada J, Fushimi Y, Shimoda M, Tatsumi F, Nakanishi S, Mune T, Kaku K, Kaneto H. Kimura T, et al. Among authors: kaneto h. J Diabetes Res. 2024 Jan 4;2024:5880589. doi: 10.1155/2024/5880589. eCollection 2024. J Diabetes Res. 2024. PMID: 38223524 Free PMC article.
Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis.
Iwamoto Y, Kimura T, Itoh T, Mori S, Sasaki T, Ohnishi M, Takenouchi H, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Tatsumi F, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: kaneto h. Endocr J. 2024 May 23;71(5):481-488. doi: 10.1507/endocrj.EJ23-0516. Epub 2024 Mar 7. Endocr J. 2024. PMID: 38447977 Free article.
The impact of grip strength, waist circumference, and body mass index on Hemoglobin A1c value: Cross-sectional study using outpatient clinical data in Japanese elderly patients with type 2 diabetes mellitus.
Nakanishi S, Shimoda M, Kimura T, Katakura Y, Sanada J, Fushimi Y, Iwamoto Y, Iwamoto H, Mune T, Kaku K, Kaneto H. Nakanishi S, et al. Among authors: kaneto h. Geriatr Gerontol Int. 2024 Apr;24(4):410-414. doi: 10.1111/ggi.14864. Epub 2024 Mar 15. Geriatr Gerontol Int. 2024. PMID: 38487967 Free PMC article.
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice.
Iwamoto Y, Kimura T, Dan K, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Shimoda M, Nogami Y, Shirakiya Y, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: kaneto h. Diabetes Obes Metab. 2024 Jun;26(6):2339-2348. doi: 10.1111/dom.15548. Epub 2024 Mar 19. Diabetes Obes Metab. 2024. PMID: 38504118
616 results